Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3523276011 | Product containing betamethasone and salicylic acid (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3713526010 | Betamethasone- and salicylic acid-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Betamethasone- and salicylic acid-containing product | Plays role | Antifungal therapeutic role | true | Inferred relationship | Some | ||
| Betamethasone- and salicylic acid-containing product | Is a | Betamethasone in topical dosage form | false | Inferred relationship | Some | ||
| Betamethasone- and salicylic acid-containing product | Has active ingredient | Betamethasone | true | Inferred relationship | Some | 1 | |
| Betamethasone- and salicylic acid-containing product | Has active ingredient | Adrenal hormone | false | Inferred relationship | Some | ||
| Betamethasone- and salicylic acid-containing product | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| Betamethasone- and salicylic acid-containing product | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Some | ||
| Betamethasone- and salicylic acid-containing product | Is a | Salicylic acid-containing product | true | Inferred relationship | Some | ||
| Betamethasone- and salicylic acid-containing product | Has active ingredient | Keratolytic agent | false | Inferred relationship | Some | ||
| Betamethasone- and salicylic acid-containing product | Has active ingredient | Salicylic acid | true | Inferred relationship | Some | 2 | |
| Betamethasone- and salicylic acid-containing product | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Betamethasone- and salicylic acid-containing product | Has active ingredient | Topical agent | false | Inferred relationship | Some | ||
| Betamethasone- and salicylic acid-containing product | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Betamethasone- and salicylic acid-containing product | Is a | Betamethasone-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Betamethasone- and salicylic acid-containing product in cutaneous dose form | Is a | True | Betamethasone- and salicylic acid-containing product | Inferred relationship | Some | |
| Betamethasone and salicylic acid only product | Is a | True | Betamethasone- and salicylic acid-containing product | Inferred relationship | Some | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Is a | False | Betamethasone- and salicylic acid-containing product | Inferred relationship | Some | |
| Betamethasone+salicylic acid 0.05/3% scalp application | Is a | False | Betamethasone- and salicylic acid-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR